In inflammatory bowel disease (IBD), miR-23a and miR-155 enhance the deleterious effects of neutrophils by targeting lamin B1 and RAD51 (a homologous recombination regulator), inhibiting tissue healing responses (148). The gene discussed is LMNB1; the disease is inflammatory bowel disease.